Obata A - Search Results

1

Basic characterization of 64Cu-ATSM as a radiotherapy agent.

Obata A, Kasamatsu S, Lewis JS, Furukawa T, Takamatsu S, Toyohara J, Asai T, Welch MJ, Adams SG, Saji H, Yonekura Y, Fujibayashi Y. Obata A, et al. Nucl Med Biol. 2005 Jan;32(1):21-8. doi: 10.1016/j.nucmedbio.2004.08.012. Nucl Med Biol. 2005. PMID: 15691658

2

Intra-tumoral distribution of (64)Cu-ATSM: a comparison study with FDG.

Obata A, Yoshimoto M, Kasamatsu S, Naiki H, Takamatsu S, Kashikura K, Furukawa T, Lewis JS, Welch MJ, Saji H, Yonekura Y, Fujibayashi Y. Obata A, et al. Nucl Med Biol. 2003 Jul;30(5):529-34. doi: 10.1016/s0969-8051(03)00047-7. Nucl Med Biol. 2003. PMID: 12831991

3

Production of therapeutic quantities of (64)Cu using a 12 MeV cyclotron.

Obata A, Kasamatsu S, McCarthy DW, Welch MJ, Saji H, Yonekura Y, Fujibayashi Y. Obata A, et al. Nucl Med Biol. 2003 Jul;30(5):535-9. doi: 10.1016/s0969-8051(03)00024-6. Nucl Med Biol. 2003. PMID: 12831992

4

Radiolabeled choline as a proliferation marker: comparison with radiolabeled acetate.

Yoshimoto M, Waki A, Obata A, Furukawa T, Yonekura Y, Fujibayashi Y. Yoshimoto M, et al. Among authors: obata a. Nucl Med Biol. 2004 Oct;31(7):859-65. doi: 10.1016/j.nucmedbio.2004.05.002. Nucl Med Biol. 2004. PMID: 15464387

5

Retention mechanism of hypoxia selective nuclear imaging/radiotherapeutic agent cu-diacetyl-bis(N4-methylthiosemicarbazone) (Cu-ATSM) in tumor cells.

Obata A, Yoshimi E, Waki A, Lewis JS, Oyama N, Welch MJ, Saji H, Yonekura Y, Fujibayashi Y. Obata A, et al. Ann Nucl Med. 2001 Dec;15(6):499-504. doi: 10.1007/BF02988502. Ann Nucl Med. 2001. PMID: 11831397

6

Functional role of sialyl Lewis X and fibronectin-derived RGDS peptide analogue on tumor-cell arrest in lungs followed by extravasation.

Saiki I, Koike C, Obata A, Fujii H, Murata J, Kiso M, Hasegawa A, Komazawa H, Tsukada H, Azuma I, Okada S, Oku N. Saiki I, et al. Among authors: obata a. Int J Cancer. 1996 Mar 15;65(6):833-9. doi: 10.1002/(SICI)1097-0215(19960315)65:6<833::AID-IJC21>3.0.CO;2-3. Int J Cancer. 1996. PMID: 8631600

7

Dynamic contrast-enhanced MRI of the liver in Mrp2-deficient rats using the hepatobiliary contrast agent Gd-EOB-DTPA.

Saito S, Obata A, Kashiwagi Y, Abe K, Murase K. Saito S, et al. Among authors: obata a. Invest Radiol. 2013 Jul;48(7):548-53. doi: 10.1097/RLI.0b013e3182856a06. Invest Radiol. 2013. PMID: 23442774

8

A new pseudo-peptide of Arg-Gly-Asp (RGD) with inhibitory effect on tumor metastasis and enzymatic degradation of extracellular matrix.

Fujii H, Nishikawa N, Komazawa H, Suzuki M, Kojima M, Itoh I, Obata A, Ayukawa K, Azuma I, Saiki I. Fujii H, et al. Among authors: obata a. Clin Exp Metastasis. 1998 Jan;16(1):94-104. doi: 10.1023/a:1006520220426. Clin Exp Metastasis. 1998. PMID: 9502081

9

Clinical significance of p53 functional loss in squamous cell carcinoma of the oropharynx.

Obata A, Eura M, Sasaki J, Saya H, Chikamatsu K, Tada M, Iggo RD, Yumoto E. Obata A, et al. Int J Cancer. 2000 Mar 20;89(2):187-93. doi: 10.1002/(sici)1097-0215(20000320)89:2<187::aid-ijc14>3.0.co;2-v. Int J Cancer. 2000. PMID: 10754498

10

Gd-EOB-DTPA-enhanced-MR imaging in the inflammation stage of nonalcoholic steatohepatitis (NASH) in mice.

Yamada T, Obata A, Kashiwagi Y, Rokugawa T, Matsushima S, Hamada T, Watabe H, Abe K. Yamada T, et al. Among authors: obata a. Magn Reson Imaging. 2016 Jul;34(6):724-729. doi: 10.1016/j.mri.2016.03.009. Epub 2016 Mar 12. Magn Reson Imaging. 2016. PMID: 26979540

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

223 results

Search Page

Filters